# Real-World Safety and Effectiveness of Voretigene Neparvovec: Results up to 2 Years from the Prospective, Registry-Based PERCEIVE Study

*PRI Rank #16 · Topics and Trends in Most Cited Retinal Development and Disorders Papers, Class of 2026*

*Canonical URL: https://pri.pepkio.com/top-papers/retinal-development-and-disorders/2026/rank-16*

| Field | Value |
| --- | --- |
| Rank | #16 |
| 18m citations | 24 |
| Journal | Biomolecules |
| Year | 2024 |
| DOI | 10.3390/biom14010122 |
| Corresponding authors | M. Dominik Fischer |
| Institution | University of Tübingen, Germany |

**Ranking page:** [Topics and Trends in Most Cited Retinal Development and Disorders Papers, Class of 2026](https://pri.pepkio.com/top-papers/retinal-development-and-disorders/2026)

**Paper link:** [10.3390/biom14010122](https://doi.org/10.3390/biom14010122)

## Topics

voretigene neparvovec · RPE65-mediated inherited retinal dystrophy · gene therapy · PERCEIVE study · registry-based observational study · post-authorization safety study · chorioretinal atrophy · Ocular inflammation · Full-field stimulus testing · Visual acuity · treatment-emergent adverse events · Real-world outcomes · viable retinal cells · ocular TEAEs

## Cite this ranking

```
Pepkio Research Index (PRI). Topics and Trends in Most Cited Retinal Development and Disorders Papers, Class of 2026. https://pri.pepkio.com/top-papers/retinal-development-and-disorders/2026. Accessed 2026-10-28.

Zheng Su, Tinsley Li, Thematic Shifts in Early-High-Impact Cancer Genomics and Diagnostics Research: A Bibliometric and Semantic Analysis. bioRxiv 2026.07.04.736459; doi: https://doi.org/10.64898/2026.07.04.736459
```